Stockreport

7% Weight Loss in Animals Supports Lexaria's Next 8-week Animal Study [Yahoo! Finance]

Lexaria Bioscience Corp.  (LEXX) 
PDF drug delivery platforms, informs that its wholly-owned and patented DehydraTECH-CBD formulation, when administered to rodents in an 8-week study (DIAB-A22-1), resulted i [Read more]